Skip to content
Tiratricol
Tiratricol is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target thyroid hormone receptor beta and thyroid hormone receptor alpha.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
D: Dermatologicals
D11: Other dermatological preparations in atc
D11A: Other dermatological preparations in atc
D11AX: Other dermatological preparations in atc
D11AX08: Tiratricol
H: Systemic hormonal preparations, excl. sex hormones and insulins
H03: Thyroid therapy drugs
H03A: Thyroid preparations
H03AA: Thyroid hormones
H03AA04: Tiratricol
HCPCS
No data
Clinical
Clinical Trials
39 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients10111
Respiratory tract infectionsD012141J06.91314
BronchitisD001991J40123
AsthmaD001249EFO_0000270J4511
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
CoughD003371HP_0012735R051214
Hemophilia bD002836D6711
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeuralgiaD009437EFO_000943011
Hiv infectionsD015658EFO_0000764B2011
SinusitisD012852EFO_0007486J3211
Common coldD003139EFO_0007214J0011
Communicable diseasesD00314111
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Therapeutic equivalencyD01381011
Mucociliary clearanceD00907911
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PneumoniaD011014EFO_0003106J1811
Lung diseasesD008171EFO_0003818J98.411
Pulmonary fibrosisD011658J84.1011
Back painD001416HP_0003418M5411
InfectionsD007239EFO_000054411
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameTIRATRICOL
INNtiratricol
Description
Tiratricol (also known as TRIAC or triiodothyroacetic acid) is a thyroid hormone analogue. Triiodothyroacetic acid is also a physiologic thyroid hormone that is present in the normal organism in low concentrations.
Classification
Small molecule
Drug class
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
O=C(O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1
Identifiers
PDB1NQ2
CAS-ID51-24-1
RxCUI13982
ChEMBL IDCHEMBL41632
ChEBI ID
PubChem CID5803
DrugBankDB03604
UNII ID29OQ9EU4R1 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
THRB
THRB
THRA
THRA
Organism
Homo sapiens
Gene name
THRB
Gene synonyms
ERBA2, NR1A2, THR1
NCBI Gene ID
Protein name
thyroid hormone receptor beta
Protein synonyms
c-erbA-2, c-erbA-beta, Nuclear receptor subfamily 1 group A member 2, oncogene ERBA2, thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian)
Uniprot ID
Mouse ortholog
Thrb (21834)
thyroid hormone receptor beta (Q3TY80)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 55 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
10 adverse events reported
View more details